Company news: Avanir Pharmaceuticals
Avanir Pharmaceuticals said it will launch Nuedexta, its newly approved drug for treating pseudobulbar affect (PBA), in first quarter 2011 ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.